Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.

Saved in:
Bibliographic Details
Title: Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.
Authors: Adib E; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts., Nassar AH; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, Connecticut., Abou Alaiwi S; Department of Cardiology, Yale New Haven Hospital, New Haven, Connecticut., Baca SC; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hanlon T; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts., Bou Farhat E; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Tang Y; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Corona RI; Department of Human Genetics, University of California, Los Angeles, Los Angeles, California.; Department of Computational Medicine, University of California, Los Angeles, Los Angeles, California.; Department of Biostatistics, University of California, Los Angeles, Los Angeles, California., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Fonseca MAS; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California., Acosta AM; Department of Pathology, Indiana University Health University Hospital, Indianapolis, Indiana., Losko M; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts., Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; McGraw/Patterson Center for Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Lawrenson K; Department of Obstetrics and Gynecology, University of Texas Health San Antonio, San Antonio, Texas.; Center for Inherited Oncogenesis, University of Texas Health San Antonio, San Antonio, Texas., Mouw KW; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kwiatkowski DJ; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2026 Jun 03; Vol. 24 (6), pp. 504-517.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3125
DOI:10.1158/1541-7786.MCR-25-1385